간편하게 보는 뉴스는 유니콘뉴스
ReNAgade Therapeutics Appoints Paul Perreault to Board of Directors

· 등록일 Dec. 07, 2023 14:30

· 업데이트일 2023-12-07 15:02:49

CAMBRIDGE, MASS.--(Business Wire / Korea Newswire)--ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced the appointment of Paul Perreault to its Board of Directors, effective December 5, 2023. Mr. Perreault most recently served as Chief Executive Officer of CSL and brings over 40 years of leadership experience across the biotechnology industry.

“Paul is a distinguished industry executive recognized for his extensive track record in drug development and was integral to the growth of CSL to become an international leader in the field. His leadership and extensive knowledge of the biotech industry will be an invaluable addition to our company as we continue to build our portfolio of novel RNA medicines,” said Amit D. Munshi, Chief Executive Officer of ReNAgade. “We are pleased to welcome Paul to the ReNAgade team and look forward to his contributions.”

“I am thrilled to join ReNAgade at this exciting time for the company,” said Mr. Perreault. “ReNAgade is led by a world-class executive team, and its innovative technologies have the potential to drive the field of RNA medicines forward on an unprecedented scale in the coming years.”

Mr. Perreault brings more than 40 years of experience in the global biotechnology and pharmaceutical industries, most recently as CEO and Managing Director of CSL. Within his 25-year career with CSL, he was responsible for operations in more than 40 countries, including major manufacturing sites in the U.S., Switzerland, Germany and Australia, and an extensive network of plasma collection centers throughout North America and Germany. He previously served in senior leadership roles at various companies in the space including Wyeth, Centeon, Aventis Bioservices and Aventis Behring, and served on the Board of Directors of the Pharmaceutical Research and Manufacturers of America (PhRMA). In 2019, Mr. Perreault was included in Harvard Business Review’s CEO 100 List and recognized as one of the best performing CEOs in the world. He earned his B.S. in Psychology from the University of Central Florida and completed advanced business management training at Kellogg School of Management and Wharton School of the University of Pennsylvania.

About ReNAgade Therapeutics

ReNAgade exists to unlock the potential for RNA medicines to treat disease anywhere in the body. We combine our novel RNA delivery platforms with a comprehensive RNA platform allowing for an all-RNA system for coding, editing, and gene insertion to develop new medicines.

To accelerate the future of medicine, we bring together a team with deep RNA and delivery expertise to develop paradigm-shifting RNA medicines.

ReNAgade Therapeutics—RNA Without Limits

For more information about the company, its technologies, and its leadership, visit www.renagadetx.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20231205970464/en/

Website: https://renagadetx.com/ View Korean version of this release Contact ReNAgade Therapeutics
Investor Relations
Argot Partners
Emily Brabbit
(212) 600-1902
[email protected]

Media Relations
Argot Partners
Sarah Sutton
(212) 600-1902
[email protected]
This news is a press release from the provider.
Korea Newswire is committed to verifying the transparency of providers and eliminating content errors.
You can receive press releases from this company or in industries of interest via email and RSS for free. Subscribe> News provided byReNAgade Therapeutics Distribution Channel Health Pharmaceutical Biotechnology Personnel anouncement Overseas
인기 기사04.03 10시 기준
평택--(뉴스와이어)--프로그레시브 시팅 솔루션 시디즈가 한국e스포츠협회(KeSPA)와 파트너십 확장 협약을 체결하고 e스포츠 활성화 사업에 협력한다. 시디즈 프리미엄 게이밍 의자 ‘GC PRO’ 한국콘텐츠진흥원이...
용인--(뉴스와이어)--한국저영향개발협회(회장 최경영)는 23일 ESG산업가치연구원(원장 조경선)과 업무협약을 체결했다. 협약식은 한국저영향개발협회 최경영 회장, 김신 부회장, 임웅재 팀장, ESG산업가치연구원 조경선 원장 등이 참석한 가운데 진행됐다. 23일 한국저영향개발협회와 ESG산업가치연구원이...
논산--(뉴스와이어)--금강대학교는 경기평택항만공사, 국가발전정책연구원, 몽골 정책분석연구센터(CPRA)와 12월 8일 평택항 마린센터에서 공동 연구 및 인재 양성을 위한 4개 기관 간 업무 협약을 체결했다고 밝혔다. 금강대학교는 경기평택항만공사, 국가발전정책연구원,...
인천--(뉴스와이어)--항공안전기술원(원장 이대성)은 11월 21일 드론의 하늘길 시대를 열기 위한 기반기술인 드론교통관리시스템을 실증하는 ‘2023년 K-드론시스템 실증지원 사업’ 실증시연회를 대구광역시 한국수자원공사 군위댐 지사에서 개최했다. 항공안전기술원 홍보 영상 ...
성남--(뉴스와이어)--아이브릭스(대표 채종현)는 오는 5월 1일(수)부터 3일(금)까지 3일간 서울 삼성역 코엑스에서 열리는 ‘AI EXPO KOREA 2024(국제인공지능대전)’에 참가해 자체 개발 소규모 거대언어모델(sLLM) ‘Cerebro (이하 세레브로)’를 선보인다고 15일 밝혔다. ...
벨링햄, 워싱턴--(뉴스와이어)--세계 최고 수준의 에이전트 중심형 부동산 중개법인이자 eXp 월드 홀딩스(eXp World Holdings, Inc., 나스닥: EXPI)의 핵심 자회사인 eXp 리얼티®(eXp Realty®)는 럭셔리 부동산 프로그램인 ‘eXP 럭셔리(eXp Luxury)’가 지속적인 성장세를 보이면서 호주, 뉴질랜드, 남아프리카공화국, 영국...
API
fg
유니콘뉴스는 보도자료 배포 서비스입니다.
여기에 뉴스를 등록하면 언론이 보도하고 널리 배포됩니다.